patent/FR-2885807-A1

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d23394766a14e6153f4f8e25c0ea1c4
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate	2005-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_537ed41ada7bd9b04c2dfe85034f2f9c
publicationDate	2006-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	FR-2885807-A1
titleOfInvention	SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD
abstract	A solid sustained release pharmaceutical composition comprising the active ingredient 1- (2,3,4-trimethoxybenzyl) piperazine, or a pharmaceutically acceptable salt of 1- (2,3,4-trimethoxybenzyl) piperazine, in combination with at least one polyethylene and at least one lubricating agent, and one or more pharmaceutically acceptable excipients.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012515757-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010084397-A3
priorityDate	2005-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1108424-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03043610-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0673649-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2818549-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1195160-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21109 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554682

Total number of triples: 23.